Earth BioGenome Project

Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome

Retrieved on: 
Tuesday, July 12, 2022
Technology, Research, Genetics, Other Technology, Software, Biotechnology, Health, Other Science, Science, Borneo, Forest, Technology, Howard Hughes Medical Institute, Bird, Disease, Life, African bush elephant, Multimedia, IUCN, News, Biology, Amphibian, Reptile, Vertebrate Genomes Project, African elephant, Genomics, Risk, Human genome, Fish, Gaps, CEO, Human, Woolly mammoth, Arima, Biodiversity, Elephant, Elephas, Publication, Rockefeller University, Genome, Vertebrate, Health, Mammal, List of life sciences, Genetic code, Climate change, Software, Doctor of Philosophy, DNA, Earth BioGenome Project, Agriculture, Antibiotics, Hunting, VGP, Colossal

Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project (VGP ) have become the first to successfully sequence the entire Asian elephant genome, introducing a new wave of innovative and disruptive animal conservation.

Key Points: 
  • Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project (VGP ) have become the first to successfully sequence the entire Asian elephant genome, introducing a new wave of innovative and disruptive animal conservation.
  • View the full release here: https://www.businesswire.com/news/home/20220712005534/en/
    Arima Hi-C Assembly of the Asian Elephant (Elephas maximus) Genome.
  • The first phase of this landmark project which was completed in June included the sequencing, assembly, and annotation of the Asian elephant (Elephas maximus) genome.
  • Following the efforts given to the T2T human genome project, the Asian elephant will be one of the first genomes to be sequenced T2T.

Colossal Biosciences and the Vertebrate Genomes Project Will Preserve the Genetic Code of all Endangered Elephant Species Through Genomic Sequencing

Retrieved on: 
Friday, October 1, 2021
Veterinary, Environment, Research, Genetics, Philanthropy, Biotechnology, Health, Other Philanthropy, Science, Publication, Biodiversity, CRISPR, Bird, DNA, Vertebrate Genomes Project, Population, African bush elephant, Reptile, Biology, CEO, Genomics, Vertebrate, Life, Elephas, Disease, Earth BioGenome Project, Howard Hughes Medical Institute, Risk, Technology, Elephant, Genetic engineering, Research, Fish, Genetic code, Mammal, Amphibian, Doctor of Philosophy, De-extinction, Rockefeller University, IUCN, Antibiotics, Hunting

Colossal and the Vertebrate Genomes Project (VGP) embark on the worlds first effort to obtain the genetic code of the existing elephant lineage, of which all three species are endangered.

Key Points: 
  • Colossal and the Vertebrate Genomes Project (VGP) embark on the worlds first effort to obtain the genetic code of the existing elephant lineage, of which all three species are endangered.
  • Following the VGP principles, these genomes will be made publicly available to be used for research without use restrictions.
  • The Asian and African elephants are classified as Endangered, and the Forest elephant is classified as Critically Endangered by the IUCN .
  • By sequencing these three elephant species, we will genetically preserve the entire order.

PacBio Partners with The European Reference Genome Atlas Initiative

Retrieved on: 
Monday, September 27, 2021
Molecule, Leibniz Association, Pacific Biosciences, Abraxis BioScience, Biodiversity, Partnership, Biomedical Research, Research, Climate, Climate change, Security (finance), Genome, Health, NASDAQ, Single-molecule real-time sequencing, U.S. Securities and Exchange Commission, Zoo, Vertebrate Genomes Project, High fidelity, Microbiology, Research group, Biology, Private Securities Litigation Reform Act, Royal commission, Genomics, EBP, Company, Program, General manager, Growth, Cataloging, Genetic variation, Risk, Horizon Europe, Earth BioGenome Project, Chair, Wellcome Sanger Institute, European Commission, EMEA, Securities Exchange Act of 1934, Acceleration, Nasdaq, GLOBE, Agriculture, Antibiotics

Biodiversity is under threat worldwide with a high number of European species at risk of extinction1.

Key Points: 
  • Biodiversity is under threat worldwide with a high number of European species at risk of extinction1.
  • Together, PacBio and ERGA aim to put Europes biodiversity on the path to recovery by 2030, said Neil Ward, Vice President and General Manager of EMEA at PacBio.
  • ERGA seeks to increase coordination across all countries of the European continent, in tandem with international partners, to generate reference-quality, complete and error-free genome assemblies for at least 200,000 plant and animal species - across Europe.
  • Were excited to welcome PacBio to the ERGA initiative and look forward to our coordinated effort to generate complete reference genomes for all European biodiversity, which will accelerate conservation initiatives and advance biodiversity genomics innovation.

Pacific Biosciences to Support Sequencing of California Species for the Earth BioGenome Project

Retrieved on: 
Tuesday, February 25, 2020
Branches of biology, Biology, Genetics, Molecular biology, Genomics, Pacific Biosciences, DNA, Genetic mapping, Bioinformatics, Earth BioGenome Project, Genome, Read

MENLO PARK, Calif. and DAVIS, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- The Earth BioGenome Project (EBP) and Pacific Biosciences of California, Inc.(Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that PacBio will support the sequencing of ecologically important organisms in the state of California through the EBP.

Key Points: 
  • MENLO PARK, Calif. and DAVIS, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- The Earth BioGenome Project (EBP) and Pacific Biosciences of California, Inc.(Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that PacBio will support the sequencing of ecologically important organisms in the state of California through the EBP.
  • Currently, fewer than 4,500 or about 0.3 per cent of all known eukaryotic species have had their genome sequenced, with approximately 100 at reference quality.
  • For more information please visit www.earthbiogenome.org/
    Pacific Biosciences of California, Inc.(NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems.
  • Pacific Biosciences technology provides high accuracy, ultra-long reads, uniform coverage, and the ability to simultaneously detect epigenetic changes.